ArticleProceedings (Baylor University. Medical Center)2020

Clinical and histological response to combination nivolumab and ipilimumab in metastatic renal cell carcinoma.

Yadav Pandey et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.